#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Idiopathic pulmonary fibrosis Hyperinsulinism Sexually transmitted disease Marginal zone lymphoma Hepatic angiosarcoma Nephrotic syndrome Neuroendocrine cell hyperplasia of infancy Superficial vein thrombosis Becker's muscular dystrophy Osteogenesis imperfecta Rheumatoid arthritis Retinoblastoma Cortical dysplasia Mucopolysaccharidosis II Craniopharyngioma More trials…

    Learn about Rare Diseases

    Leiomyosarcoma – Diagnostics Marginal zone lymphoma – Treatment Glycogen storage disease type II – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Brain stem glioma – Trials in Disease Proteus syndrome – Treatment Vascular malformation – Trials in Disease Pleural mesothelioma malignant – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Life with Disease Haemophilia A without inhibitors More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Posenacaftor Tucidinostat Piperacillin Sodium S230815-2 Pitavastatin Calcium Tipranavir SAR444336 ALLO-QUADCAR01-T VX-407 Blu-451 Chlorphenamine Maleate Dulaglutide Laronidase SAR443820 Ribonucleic Acid K30 Zalunfiban Losartan Infigratinib Chlorhexidine Gluconate Bupropion Hydrochloride More therapies…

    Learn about Your Condition

    Knee arthroplasty Bone metabolism disorder Congenital pseudarthrosis Carotid arteriosclerosis Glomerulonephritis membranous Escherichia infection Acute myeloid leukaemia Optic atrophy Richter's syndrome Autoimmune disorder Transitional cell carcinoma Chronic kidney disease Trisomy 21 Endocarditis Marfan's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms

    Recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • SELTOREXANT
    Bulgaria Czechia Italy Poland Portugal Romania +3

  • Study on the Effectiveness and Safety of Deucravacitinib for Children and Teens with Juvenile Psoriatic Arthritis

    Recruiting

    3 1
    Investigated Drugs:
    • Deucravacitinib
    Bulgaria Czechia Germany Italy Romania Spain

  • Study on the Safety and Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Adults with Severe or Moderately Severe Hemophilia B and AAV5 Antibodies

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor IX deficiency
    Investigated Drugs:
    • Etranacogene Dezaparvovec
    Bulgaria Poland

  • Study Comparing Surgery and Chemoradiotherapy with Capecitabine for Early Rectal Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Capecitabine
    France The Netherlands

  • Study on the Safety and Effectiveness of C1 Esterase Inhibitor and Sodium Chloride for Patients with Aneurysmal Subarachnoid Hemorrhage

    Recruiting

    2 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • C1 Esterase Inhibitor (Human)
    • Sodium Chloride
    The Netherlands

  • Study on the Effects of Pitolisant Hydrochloride for Patients with Prader-Willi Syndrome

    Recruiting

    3 1
    Investigated Diseases:
    • Prader-Willi syndrome
    Belgium Czechia Denmark France Germany Italy +4
Previous Page
1 … 243 244 245 246 247 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!